Nonsteroidal Anti-Inflammatory Drugs and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Expert Review of Cardiovascular Therapy - United Kingdom
doi 10.1586/14779072.2015.1071665
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Risk of Nonsteroidal Anti-Inflammatory Drugs and Safety of Acetaminophen in Patients With Advanced Liver Disease

Clinical Liver Disease
Hepatology
2018English

Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2012English

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies

Frontiers in Medicine
Medicine
2020English

Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus

Gastroenterology
HepatologyGastroenterology
2011English

Antenatal Exposure to Nonsteroidal Anti-Inflammatory Drugs and Risk of Neonatal Hypertension

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Use

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1988English

Risk of Ulcer Bleeding in Patients Infected With Helicobacter Pylori Taking Non-Steroidal Anti-Inflammatory Drugs

Gut
Gastroenterology
2000English

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in COVID-19 Patient

Disaster and Emergency Medicine Journal
2020English

Risk Factors and Prevention of Dabigatran-Related Gastrointestinal Bleeding in Patients With Atrial Fibrillation

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy